Order Careers Contact Us Sign in Adaptive Biotechnologies Order Careers
Contact Us Sign in Immune Profiling Platform Platform OverviewPublications
Products & Services LIFE SCIENCES RESEARCHimmunoSEQ®CLINICAL
DIAGNOSTICSclonoSEQ®PipelineDRUG DISCOVERYCellular TherapyVaccines
PARTNERSHIPS Cancer Cellular TherapyAntigen MapBiopharma PartnershipsStrategic
Collaborators About Us Our StoryCultureCareersNewsroomContact Us OUR
INTELLECTUAL PROPERTY Adaptive’s patent portfolio includes the following
issued U.S. patents: U.S. Patent No. 8,236,503, entitled “Methods of
Monitoring Conditions by Sequence Analysis” U.S. Patent No. 8,507,205,
entitled “Single Cell Analysis by Polymerase Cycling Assembly” U.S. Patent No.
8,628,927, entitled “Monitoring Health and Disease Status Using Clonotype
Profiles” U.S. Patent No. 8,685,898, entitled “Adaptive Immunity Profiling and
Methods for Generation of Monoclonal Antibodies” U.S. Patent No. 8,691,510,
entitled “Sequence Analysis of Complex Amplicons” U.S. Patent No. 8,748,103,
entitled “Monitoring Health and Disease Status Using Clonotype Profiles” U.S.
Patent No. 8,795,970, entitled “Methods of Monitoring Conditions by Sequence
Analysis” U.S. Patent No. 8,883,418, entitled “Measurement of The
Immunological Diversity and Evaluation of the Effects of a Treatment Through
Studying V(D)J Diversity” U.S. Patent No. 9,043,160, entitled “Method of
Determining Clonotypes and Clonotype Profiles” U.S. Patent No. 9,150,905,
entitled “Compositions and Method for Measuring and Calibrating Amplification
Bias in Multiplexed PCR Reactions” U.S. Patent No. 9,181,590, entitled
“Quantification of Adaptive Immune Cell Genomes in a Complex Mixture Of Cells”
U.S. Patent No. 9,181,591, entitled “Quantification of Adaptive Immune Cell
Genomes in a Complex Mixture Of Cells” U.S. Patent No. 9,217,176 entitled
“Methods of Monitoring Conditions by Sequence Analysis” U.S. Patent No.
9,228,232 entitled “Methods of Monitoring Conditions by Sequence Analysis”
U.S. Patent No. 9,279,159 entitled “Quantification of Adaptive Immune Cell
Genomes in a Complex Mixture of Cells” U.S. Patent No. 9,347,099 entitled
“Single Cell Analysis by Polymerase Cycling Assembly” U.S. Patent No.
9,365,901 entitled “Monitoring Immunoglobulin Heavy Chain Evolution in B-cell
Acute Lymphoblastic Leukemia” U.S. Patent No. 9,371,558 entitled “Compositions
and Method for Measuring and Calibrating Amplification Bias in Multiplexed PCR
Reactions” U.S. Patent No. 9,394,567 entitled “Detection and Quantification of
Sample Contamination in Immune Repertoire Analysis” U.S. Patent No. 9,416,420
entitled “Monitoring Health and Disease Status Using Clonotype Profiles” U.S.
Patent No. 9,499,865 entitled “Detection and Measurement of Tissue-
Infiltrating Lymphocytes” U.S. Patent No. 9,506,119 entitled “Method of
Sequence Determination Using Sequence Tags” U.S. Patent No. 9,512,487 entitled
“Monitoring Health and Disease Status Using Clonotype Profiles” U.S. Patent
No. 9,523,129 entitled “Sequence Analysis of Complex Amplicons” U.S. Patent
No. 9,528,160 entitled “Rare Clonotypes and Uses Thereof” U.S. Patent No.
9,708,657, entitled “Method for Generating Clonotype Profiles Using Sequence
Tags” U.S. Patent No. 9,809,813, entitled “Method of Measuring Adaptive
Immunity”, exclusively licensed from the Fred Hutchinson Cancer Research
Center” U.S. Patent No. 9,824,179, entitled “Diagnosis of Lymphoid
Malignancies and Minimal Residual Disease Detection” U.S. Patent No.
10,066,265 entitled “Determining Antigen-Specific T-Cells” U.S. Patent No.
10,077,473 entitled “Method For Genotyping Clonotype Profiles Using Sequence
Tags” U.S. Patent No. 10,077,478 entitled “Determining Paired Immune Receptor
Chains From Frequency Matched Subunits” U.S. Patent No. 10,150,996 entitled
“Quantification of Adaptive Immune Cell Genomes in a Complex Mixture of Cells”
Corporate/Research (855) 466-8667 Diagnostics (888) 522-8988 Immune Profiling
PlatformPlatform Overview Publications Products & ServicesLIFE SCIENCES
RESEARCH immunoSEQ® CLINICAL DIAGNOSTICS clonoSEQ® Pipeline DRUG DISCOVERY
Cellular Therapy Vaccines PartnershipsCancer Cellular Therapy Antigen Map
Biopharma Partnerships Strategic Collaborators About UsOur Story Culture
Careers News & Events Contact Us © Adaptive Biotechnologies. All Rights
Reserved. Terms of Use Online Privacy Policy Privacy Shield Policy HIPAA
Policy Code of Conduct Patents & Trademarks Licenses